Search
23 studies match these filters. Showing 1–23 of 23 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 374 sites in total | Recruiting | Phase 3 | 600target | 374 / 38 | 2025 | Sep 16, 2026 | |
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 370 sites in total | Recruiting | Phase 2 / Phase 3 | 1,092target | 370 / 28 | 2025 | Aug 28, 2026 | |
| NCT06588855 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 200 sites in total | Recruiting | Phase 3 | 350target | 200 / 30 | 2024 | Aug 5, 2026 | |
| NCT07382167 | A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily f… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 3 | 692target | 109 / 1 | 2026 | Jun 4, 2026 | |
| NCT05561114 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus To evaluate the safety and efficacy of the ProTractX3™ DCB for the treatment of benign esophageal strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 34 sites in total · contact listed | Recruiting | Phase 3 | 198target | 34 / 1 | 2023 | Jun 25, 2025 | |
| NCT06571669 | BOOM-IBD2 Pivotal Clinical Trial Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailb… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 19 sites in total · contact listed | Recruiting | Not applicable | 137target | 19 / 1 | 2025 | Aug 6, 2026 | |
| NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months… ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 101 sites in total · contact listed | Recruiting | Phase 4 | 200target | 101 / 1 | 2025 | Sep 15, 2026 | |
| NCT06215716 | A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 356 sites in total | Recruiting | Phase 3 | 1,650target | 356 / 18 | 2023 | Aug 7, 2026 | |
| NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associated steatotic liver disease (MASLD). The study will enroll adults who have MASLD based on non-invasi… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 563 sites in total · contact listed | Recruiting | Phase 3 | 4,500target | 563 / 34 | 2025 | Sep 8, 2026 | |
| NCT05561127 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 33 sites in total · contact listed | Recruiting | Phase 3 | 171target | 33 / 1 | 2023 | Jun 25, 2025 | |
| NCT06880055 | Shield Post-Approval Study Protocol The Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an average risk population at a second round of testing for individuals between the ages of 45 and 81 at average risk of CRC usi… ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 69 sites in total | Recruiting | 3,375target | 69 / 1 | 2025 | Aug 7, 2026 | ||
| NCT06906562 | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 2 | 40target | 109 / 1 | 2025 | Feb 17, 2026 | |
| NCT06237452 | VE303 for Prevention of Recurrent Clostridioides Difficile Infection The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 215 sites in total | Recruiting | Phase 3 | 852target | 215 / 24 | 2024 | Sep 14, 2026 | |
| NCT05080673 | Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 493 sites in total · contact listed | Recruiting | Not applicable | 9,500target | 493 / 2 | 2022 | Sep 2, 2026 | |
| NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 1,077 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 1,912target | 1,077 / 3 | 2022 | Sep 2, 2026 | |
| NCT06937177 | Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up to 120 patients. Patients will be enrolled into two cohorts 1) patients with newly diagnosed, advanced, unresectable colorectal cancer (CRC) o… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 26 sites in total · contact listed | Recruiting | Phase 2 | 120target | 26 / 2 | 2025 | Jul 15, 2026 | |
| NCT07069673 | Abbott Cephea Mitral Valve Disease Registry The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 24 sites in total · contact listed | Recruiting | 1,000target | 24 / 1 | 2025 | Sep 10, 2026 | ||
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 745 sites in total · contact listed | Recruiting | 2,000target | 745 / 1 | 2022 | Sep 2, 2026 | ||
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folini… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 239 sites in total | Recruiting | Phase 3 | 1,000target | 239 / 22 | 2024 | Aug 28, 2026 | |
| NCT07282665 | A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placeb… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 185 sites in total | Recruiting | Phase 3 | 32,500target | 185 / 4 | 2025 | Sep 9, 2026 | |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 251 sites in total | Recruiting | Phase 3 | 700target | 251 / 26 | 2024 | Aug 28, 2026 | |
| NCT05125302 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 129 sites in total | Recruiting | Phase 3 | 1,059target | 129 / 2 | 2022 | Sep 14, 2026 | |
| NCT07546929 | HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed | Recruiting | Phase 2 | 300target | 25 / 1 | 2023 | Apr 23, 2026 |